Correlation Between Telomir Pharmaceuticals, and Tourmaline Bio

Can any of the company-specific risk be diversified away by investing in both Telomir Pharmaceuticals, and Tourmaline Bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Telomir Pharmaceuticals, and Tourmaline Bio into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Telomir Pharmaceuticals, Common and Tourmaline Bio, you can compare the effects of market volatilities on Telomir Pharmaceuticals, and Tourmaline Bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Telomir Pharmaceuticals, with a short position of Tourmaline Bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Telomir Pharmaceuticals, and Tourmaline Bio.

Diversification Opportunities for Telomir Pharmaceuticals, and Tourmaline Bio

-0.46

Correlation Coefficient

Telomir Pharmaceuticals,  Tourmaline Bio

Very good diversification

The 3 months correlation between Telomir and Tourmaline is -0.46. Overlapping area represents the amount of risk that can be diversified away by holding Telomir Pharmaceuticals, Commo and Tourmaline Bio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tourmaline Bio and Telomir Pharmaceuticals, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Telomir Pharmaceuticals, Common are associated (or correlated) with Tourmaline Bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tourmaline Bio has no effect on the direction of Telomir Pharmaceuticals, i.e., Telomir Pharmaceuticals, and Tourmaline Bio go up and down completely randomly.

Pair Corralation between Telomir Pharmaceuticals, and Tourmaline Bio

Given the investment horizon of 90 days Telomir Pharmaceuticals, is expected to generate 3.11 times less return on investment than Tourmaline Bio. In addition to that, Telomir Pharmaceuticals, is 2.01 times more volatile than Tourmaline Bio. It trades about 0.02 of its total potential returns per unit of risk. Tourmaline Bio is currently generating about 0.15 per unit of volatility. If you would invest  1,781  in Tourmaline Bio on September 12, 2024 and sell it today you would earn a total of  719.00  from holding Tourmaline Bio or generate 40.37% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Telomir Pharmaceuticals, Commo  vs.  Tourmaline Bio

Telomir Pharmaceuticals,

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Telomir Pharmaceuticals, Common are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very weak essential indicators, Telomir Pharmaceuticals, may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Tourmaline Bio

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Tourmaline Bio are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite quite weak primary indicators, Tourmaline Bio disclosed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Telomir Pharmaceuticals, and Tourmaline Bio

The main advantage of trading using opposite Telomir Pharmaceuticals, and Tourmaline Bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Telomir Pharmaceuticals, position performs unexpectedly, Tourmaline Bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tourmaline Bio will offset losses from the drop in Tourmaline Bio's long position.

The idea behind Telomir Pharmaceuticals, Common and Tourmaline Bio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.